US-Israel Alzheimer’s Disease Conference
Hosted by Tel Aviv University in partnership with Hebrew University and Rutgers University
The Israeli Meeting Site is supported by:
- Eli Lily (Israel)
- Tel Aviv University
- Sagol School of Neuroscience, Tel Aviv University
For more information and additional support, please visit our Runger's University meeting site
Please join us in Tel Aviv on Thursday, June 5th, 2025, to expand US-Israeli scientific & educational programs in Alzheimer's disease research
[Free registration to Israeli students and postdocs who register now]: Thanks to the generosity of our donors and supporters, a limited number of free registrations is available to Israeli students (both undergraduate and graduate) and postdoctoral fellows who register prior to May 15th. To take advantage of this offer, you must register using an official Israeli university or medical center email address (no gmail or other private email addresses allowed) and identify the name of your supervising mentor. NOTE: Register as soon as possible because once we reach the maximum number of free registrations that have been funded, the offer will expire and anyone else will need to pay the registration.
Dear Friends:
To expand opportunities for US-Israeli cooperation and collaboration in seeking a cure for Alzheimer’s disease, Tel Aviv University, The Hebrew University, and Rutgers University have joined together to organize a US-Israel Alzheimer’s Disease Conference in Tel Aviv, Israel, on Thursday, June 5th, 2025. See more information at:
https://brainhealth.rutgers.edu/us-israel/
SPEAKERS AND PROGRAM:
Date: Thursday, June 5th, 2025.
Location: The Raya and Josef Jaglom Auditorium, George S. Wise Senate Building, Tel Aviv University, Tel Aviv, Israel
8am-8:50am: Registration
8:50am-9am: Brief opening remarks.
9:00am: 1. Michal Schwarz (Weizmann Institute, Rehovot, Israel). Defeating Alzheimer’s disease by harnessing systemic immunity.
9:30am: 2. Lindsay Farrer (Boston University, Boston, Massachusetts). Genetics of Alzheimer’s disease in Jews and Israeli-Arabs.
10:00am: 3. Mark Gluck (Rutgers University, New Jersey, USA). Lifestyle, genetic, and environmental influences on Alzheimer’s risk in older African Americans.
10:30am: Midmorning Break: Coffee, tea, sweets
11:00am: 4. Mary Sano (Mt. Sinai Medical Center, New York, USA). Alzheimer’s disease and related disorders: What do we mean by “related disorders”?
11:30am: 5. Illana Gozes (Tel Aviv University, Tel Aviv, Israel). Sex influence on Alzheimer’s disease Tau pathology and drug development.
12:00pm: 6. Amos Korczyn (Tel Aviv University, Tel Aviv, Israel). Alzheimer’s is a heterogeneous syndrome, not a disease.
12:30pm-2pm. Luncheon
2:00pm: 7. David Bennet (Rush Alzheimer’s Disease Center, Illinois, USA). Charting a path to precision medicine for Alzheimer’s disease.
2:30pm: 8. Michal Beeri (Rutgers University, New Jersey, USA). The role of the glycoproteome in cognitive decline
3:00pm: Afternoon Break: Coffee, Tea, Sweets
3:30pm: 9. Hermona Soreq (The Hebrew University, Jerusalem, Israel). Transfer RNA fragments as essential fine tuners of brain functioning and Alzheimer’s disease decay
4:00pm: General Discussion: Future Directions for US-Israel Alzheimer’s Disease Collaboration and Cooperation
4:30pm-6:30pm: Poster Session/Job Fair, Reception
Posters:
Clinical – Natural History, Methodology, and Biomarkers:
1] Dr. Judit Somekh (Technion, Israel)
A computational framework for detecting inter-tissue gene-expression coordination changes with aging
2] Adi Bar (Hebrew University, Israel)
Mentor: Prof. Hermona Soreq
Altered miRNAs and tRNA fragments in Alzheimer’s disease reflect cognition differences
3] Ofer Gadish (Hebrew University, Israel)
Mentor: Prof. Hermona Soreq
Blood tRNA fragments may reflect cognitive decline in a sex- specific manner
4] Shlomit Pasternak (Sheba Medical Center, Israel)
Department of Defense Alzheimer’s Disease Blood Testing Initiative (DoD-ADBI)
5,6] Sapir Golan Shekhtman (Tel Aviv University, Israel)
Mentor: Prof. Michal Schnaider Beeri
- Behavioral Reaction to Amyloid β Status Disclosure among High-AD Risk Research Participants
- Abdominal Fat Depots are Related to Lower Cognitive Functioning and Brain Volumes in Middle-aged Males at High Alzheimer’s Risk
7] Yonatan Schwartz (Bar Ilan University, Israel)
Mentors: Profs. Michal Schnaider Beeri, Sharon Naparstek
Brain and Cognitive Reserve Measures are Associated with Cognitive Function Already in Midlife in Adults at High Risk for Alzheimer's Disease
8] Maya Zadok (Technion, Israel)
Mentors: Profs. Michal Schnaider Beeri, Roi Reichart
Dementia Through Different Eyes: Explainable Modeling of Human and LLM Perceptions
9,10] Dr. Shlomit Zorani (Sheba Medical Center, Israel)
Mentor: Prof. Ramit Ravona-Springer
- Novel Method for Objective Quantification of Apathy in Cognitively Normal Individuals at High Dementia- Risk
- Differential Apathy Profiles by Sex in Cognitively Normal Middle-Aged Offspring of Alzheimer’s Patients
11] Anat Marmor (Tel Aviv University, Israel)
Mentor: Prof. Eli Vakil
The Interplay of Cognitive Reserve and Attainment of Cognitive Potential: Predictors of Age of Onset and Cognitive Decline in Patients with Alzheimer's disease
12] Vladislav Zheleznaikov (Tel Aviv University, Israel)
Mentor: Prof. Yuval Nir
Sleep changes in the early stages of Alzheimer’s disease
13] Rotem Falach (Tel Aviv University, Israel)
Mentor: Prof. Yuval Nir
Machine Learning-Based Analysis of Zygomatic EEG During Sleep Reveals Hippocampal
Interictal Epileptiform Discharges in Epilepsy and Mild Cognitive Impairment
14] Dr. Gregory Peters-Founshtein, MD, PhD (Sheba Medical Center, Israel)
Lost in space(s): Multimodal neuroimaging of disorientation along the Alzheimer's disease continuum
15] Daniel Gutstein (Northwestern, Chicago, IL, USA)
Mentor: Dr. Tamar Gefen
Volumetric Differences in Amygdala and Hippocampus across SuperAging Phenotypes
16] Yuval Z. Katz (Tel Aviv University)
Mentors: Profs. Naama Fridmann, Ophir Keret
Subtyping reading, lexical retrieval, and syntactic impairments in primary progressive aphasia: Beyond the tripartite classification
17] Lotem Peled-Cohen (Technion)
Mentor: Prof. Roi Reichart
A Systematic Review of NLP for Dementia- Tasks, Datasets and Opportunities
Clinical Studies:
18] Van Duong (University of California Davis, USA)
Mentor: Prof. Pauline Maillard
How do educational inequities impact later-life brain health?
19] Adam Broncel, MD, PhD (Neuromedical, Lodz, Poland)
Auricular vagal nerve stimulation in patients with mild cognitive impairment due to Alzheimer’s disease: A randomized placebo double-blind study
20] Dr. Tamir Ben David (CEO Neuromedical, Lodz, Poland)
Auricular vagal nerve stimulation in patients with mild cognitive impairment due to Alzheimer’s disease: A randomized placebo double-blind study
21] Dr. Shachar Ben Izhak (Reichman University, Israel)
Enhancing Communication and Cognitive Function in Dementia: A Group-Based Intervention Integrating Cognitive Training and Validation Therapy
22] Maya Gal (Columbia University, USA)
Mentor: Prof. Sharon Sanz Simon
Menopause as a moderator of Exercise-Induced EF gains: Stretching Benefits Pre-Menopausal (<50) and Aerobic Benefits Post-Menopausal (≥50) Women with Decade-Specific Effects
23] Jason Blatt (Tel Aviv University, Israel)
Mentor: Professor Illana Gozes
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Mechanisms:
24] Artur Galushkin (Tel Aviv University, Israel)
Mentor: Prof. Illana Gozes
Circadian Clock Disruption and VIP/PACAP–ADNP Pathways in Alzheimer’s Disease: Theoretical Insights
25] Benayahu Elbaz-Eilon, PhD, Assistant Professor (Northwestern University, US)
Oligodendrocyte-derived carnosine protects the CNS from lipid peroxidation
26] Dr. Erez Matsree (Sheba Medical Center, Israel)
Barrier Disrupting Fields (BDF) Facilitate the Entry of Alpha 1 Anti-Trypsin (AAT) for Alzheimer’s Disease Treatment
27] Maya Hovav (Hebrew University, Israel)
Mentor: Prof. Asaf Marco
Intermittent Fasting-induced NRF2 Activation via Epigenetic Pathways
for Neuroprotection in Health and Disease
28] Yarden Lewit-Cohen (Tel Aviv University, Israel)
Mentor: Prof. Dan Frenkel
Expression of cellular senescence marker in astrocytes exacerbates disease pathology in Alzheimer's disease mouse model
29] Anat Haviv-Chesner (Bar Ilan University, Israel)
Mentor: Prof. Shai Rahimipour
Early diagnosis and treatment of Alzheimer’s disease by targeting toxic soluble Aβ oligomers
30] Rawan Bassal (Tel Aviv University, Israel)
Mentor: Prof. Ronit Pinkas-Kramarski
APOE4 impairs autophagy and Aβ clearance by microglial cells
31] Yaara Karasik (Bar Ilan University, Israel)
Mentor: Prof. Shahar Alon
Revealing Early Biomarkers in Alzheimer’s Disease by Creating a Super-resolution
Spatial Genomic Map in the Hippocampus at Early Stages of the Disease
32] Dr. Sara Hijazi (Oxford, UK)
Pathological tau alters head direction signaling 1 and induces spatial disorientation
33] Vania Altobelli (Tel Aviv University, Israel)
Mentor: Prof. Lihi Adler-Abramovich
Bioactive Peptide-Based Hydrogels as 3D Platforms for Modeling Neurodegeneration
34] Aleksandar Rajkovic (Ben Gurion University, Israel)
Mentor: Prof. Claude Brodski
The neuroprotective effects of BMPs against α-synuclein induced neurotoxicity in a Parkinson’s disease model
35] Dr. Ayushman Ramola (Ariel University)
Dr Arik Bergman
ULTRASENSITIVE SURFACE PLASMON RESONANCE SENSING USING PHOTONIC
CRYSTAL FIBER FOR ENHANCED DETECTION OF CANCER CELLS
MEDIA COVERAGE (SO FAR):
Jerusalem Post (2/8/2024): https://www.jpost.com/health-and-wellness/article-785783
Israel21c (2/28/2024): https://www.israel21c.org/international-conference-to-seek-alzheimers-answers/
Rutgers Daily Targum (2/15/2024): https://dailytargum.com/article/2024/02/rutgers-to-collaborate-with-tel-aviv-university-hebrew-university-on
Jewish News of UK (2/9/2024): https://www.jewishnews.co.uk/american-university-teams-up-with-israeli-scientists-to-fight-alzheimers-disease/
AAAS/EurekaAlert (2/6/2024): https://www.eurekalert.org/news-releases/1033588
NewsWise (2/6/2024): https://www.newswise.com/articles/rutgers-professors-expand-collaboration-between-us-and-israeli-scientists-seeking-a-cure-for-alzheimer-s-disease
Tel Aviv University Media: https://en-med.tau.ac.il/us-israel-alzheimers-disease-conference-24
PLEASE HELP US PROMOTE THE MEETING:
A JPEG image of our poster is attached here which we encourage you to post to all appropriate social media outlets, along with our web site: https://brainhealth.rutgers.edu/us-israel/
If you would like an 11” x 17” print copy of this poster to put on your lab or department bulletin boards, or 6” x 9” postcards to post or distribute, please email gluck@rutgers.edu with your postal mailing address and details of what you wish.
ADDITIONAL FUNDING SUPPORT WELCOME AND NEEDED:
Would you (or anyone you know) be willing to make a contribution at any level? All donations are US tax deductible through the Rutgers Foundation, a 501c3. Donations can be made by check, credit card, electronic transfer, or stock transfer.
https://brainhealth.rutgers.edu/donate/
Donations can also be made directly to The Hebrew University or Tel Aviv University (inquire for details).
Regards,
Conference Organizers: Mark Gluck & Michal Beeri (Rutgers University, USA), Illana Gozes (Tel Aviv University, Israel), Hermona Soreq (Hebrew University, Israel)